4.6 Article

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response

Related references

Note: Only part of the references are listed.
Article Oncology

Novel Molecular Targets for Hepatocellular Carcinoma

Beatrice Cavalluzzo et al.

Summary: This study aimed to identify HCC-specific overexpressed proteins and potential epitopes recognized by CD8(+) cytotoxic T cells that may share homology to viral epitopes. The results showed that circulating CD8(+) T cells targeted both HCC and viral-related epitopes, suggesting their potential use in HCC-specific immunotherapies.

CANCERS (2022)

Article Medicine, Research & Experimental

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes

Concetta Ragone et al.

Summary: This study demonstrates for the first time a high degree of homology in linear sequence, structure, and conformation between microbiota and tumor-associated antigens, suggesting that the anti-microbiota T cell memory in cancer patients may play a role in controlling cancer growth. This finding may have implications for the development of a novel preventive anti-cancer vaccine strategy.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Review Pharmacology & Pharmacy

Oncogenic activity and cellular functionality of melanoma associated antigen A3

Paula Schaefer et al.

Summary: MAGE-A3, as a cellular master switch, plays a crucial role in tumor cells, making it a potential target for cancer therapy. However, current immunotherapies targeting MAGE-A3 still require further research and improvement.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Immunology

Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery

Shin-Heng Chiou et al.

Summary: Through analyzing a large number of T cell receptor sequences, we identified T cell receptors with shared antigen specificity in a subset of non-small cell lung cancer patients and identified some specificity groups enriched in tumors. Using a yeast peptide-HLA display library, we confirmed the antigenic epitopes of one tumor-enriched specificity group, indicating that pathogen cross-reactivity may be a feature of multiple cancers.

IMMUNITY (2021)

Article Oncology

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).

Concetta Ragone et al.

Summary: This study identifies homology between viral antigens and tumor antigens, suggesting potential cross-reactive immune responses. The research indicates that antiviral T cell memory may play a significant role in combating cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Biochemistry & Molecular Biology

The tumor microenvironment

Nicole M. Anderson et al.

CURRENT BIOLOGY (2020)

Review Immunology

Selecting Target Antigens for Cancer Vaccine Development

Luigi Buonaguro et al.

VACCINES (2020)

Review Immunology

Cancer Neoantigens

Ton N. Schumacher et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)

Review Biotechnology & Applied Microbiology

Methods for improving the immunogenicity and efficacy of cancer vaccines

Lorenzo Pilla et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2018)

Article Multidisciplinary Sciences

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Erlend Stronen et al.

SCIENCE (2016)

Article Biochemistry & Molecular Biology

A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides

Linda Wooldridge et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Immunology

Why must T cells be cross-reactive?

Andrew K. Sewell

NATURE REVIEWS IMMUNOLOGY (2012)